Meroka Inc

Based in the US, Meroka Inc. specializes in technology solutions that facilitate the transition of medical practice ownership to employees, preserving community-centered healthcare. Meroka Inc. was founded in 2023 and is headquartered in New York, US.

The company focuses on supporting independent physicians in transferring ownership to their staff to maintain local healthcare integrity. It has engaged in a single investment deal, raising a total of USD 6. 00 mn in its Seed funding round on September 3, 2025, with participation from investors such as Better Tomorrow Ventures, Slow Ventures, and 8VC. The founder's history and prior ventures are not disclosed.

Meroka specializes in facilitating the transition of medical practice ownership to employees, ensuring that local businesses remain community-centered. Their primary service empowers independent physicians to transfer ownership to their staff, maintaining a community-driven model that preserves the integrity and independence of medical practices. The company collaborates with independent medical practitioners across the United States, alleviating administrative burdens and letting them focus on patient care. This approach addresses challenges in the healthcare sector, especially for independent physicians facing financial pressures from declining reimbursement rates and the dominance of fee-for-service models.

Meroka generates revenue through partnerships with independent medical practices seeking to transition ownership to their employees. Their business model is based on service agreements that support practices during the transition process. Clients engage in partnerships where Meroka provides guidance and operational support, ensuring seamless transitions for physicians and staff. Revenue comes from these service agreements, which are tailored to the unique needs of each partnership, reflecting the complexity of the transition services provided.

In September 2025, Meroka Inc raised USD 6. 00 mn in Seed funding co-led by Better Tomorrow Ventures and Slow Ventures, along with participation from 8VC and other unspecified investors. The company plans to utilize this funding to expand operations and enhance development efforts, targeting growth in new geographic regions and markets to better serve independent medical practices.